FDA Inspection 1226822 — Leslie H. Lundahl, PhD

Leslie H. Lundahl, PhD — FEI 3029464005

The FDA completed an inspection of Leslie H. Lundahl, PhD on Dec 15, 2023 in Detroit, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 15, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Detroit, MI (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
762921 CFR 312.56(c)Annual report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.